Standard Operating Procedure for Post-Approval Change Documentation and Approval
| Department | Regulatory Affairs |
| SOP No. | RA/2026/675 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 11/04/2026 |
| Effective Date | 11/04/2026 |
| Review Date | 11/04/2028 |
Purpose
This Standard Operating Procedure (SOP) outlines the systematic approach for documenting, evaluating, and obtaining approval for all post-approval changes related to products, processes, equipment, documentation, or systems within the organization. The purpose is to ensure that all changes are controlled, compliant with regulatory requirements, and do not adversely impact product quality, safety, efficacy, or regulatory status.
Scope
This SOP applies to all functional areas involved in post-approval changes including regulatory affairs, quality assurance, quality control, manufacturing, engineering, laboratory, warehousing, and documentation management. It covers all types of changes such as variations in manufacturing processes, equipment upgrades, analytical method modifications, validation updates, documentation revisions, and changes in storage or distribution conditions related to any dosage form or product released under approved regulatory submissions. Excluded from this SOP are changes related to non-critical administrative updates that do not affect product or process compliance.
Responsibilities
- Initiator: Identify the need for change, prepare initial documentation, and submit change request.
- Regulatory Affairs: Evaluate impact on regulatory submissions, prepare variation dossiers, and liaison with regulatory authorities.
- Quality Assurance: Review change documentation, ensure compliance to GMP/GDP, and approve or reject change requests.
- Quality Control: Verify analytical or testing changes and ensure appropriate validation or re-validation.
- Manufacturing/Engineering/Laboratory Personnel: Provide technical input, implement approved changes, and perform required validations.
- Documentation Control: Manage revisions and archival of related documents and records.
Accountability
The Head of Regulatory Affairs is accountable for implementation, ongoing compliance, periodic review, escalation of issues, and ensuring the effectiveness of this SOP across all applicable departments.
Procedure
1. Initiation of Change: Identify and document the need for change through a formal Change Request (CR) form specifying the nature, rationale, and expected impact of the proposed modification.
2. Pre-Assessment: Conduct an initial impact assessment involving relevant stakeholders (QA, QC, Manufacturing, Regulatory Affairs, etc.) to evaluate the scope and risk associated with the change.
3. Planning and Documentation: Develop a detailed Change Control Plan including timelines, resources, regulatory submission requirements, and validation or verification strategies as applicable.
4. Regulatory Impact Assessment: Regulatory Affairs team assesses local and international regulatory implications and prepares necessary documentation such as variation applications or notification letters for regulatory bodies.
5. Technical and Quality Review: Quality Assurance and Quality Control review and approve technical details, validation protocols, test methods, and confirm compliance with GMP and applicable standards.
6. Approval: The change request must be approved by authorized personnel from Regulatory Affairs, Quality Assurance, and affected departments before implementation.
7. Implementation: Implement changes strictly as per the approved plan ensuring personnel are trained, equipment calibrated or qualified as necessary, and all activities recorded.
8. Verification and Validation: Conduct verification activities and validation protocols to confirm that changes meet predetermined acceptance criteria without compromise to quality or compliance.
9. Documentation and Record Keeping: All documents including change requests, assessments, approvals, validation reports, and regulatory submissions must be executed, archived, and managed according to documentation control procedures.
10. Post-Implementation Review: Conduct a review to evaluate the effectiveness of the change and address any deviations or issues arising post-change.
11. Change Closure: Finalize the change control record after successful review and archive appropriately for future reference and audits.
12. Training: Provide training to impacted staff on new procedures, systems, or controls introduced through the change.
13. Deviation Handling: Any deviations or unexpected outcomes during or after implementation must be documented, investigated, and resolved per deviation management procedures.
Following this structured approach ensures regulatory compliance, maintains product and process integrity, and supports continuous improvement within a regulated pharmaceutical environment.
Abbreviations
- CR: Change Request
- QA: Quality Assurance
- QC: Quality Control
- GMP: Good Manufacturing Practice
- GDP: Good Distribution Practice
- VMP: Variation Management Process
- CAPA: Corrective and Preventive Action
Documents
- Change Request Form (Annexure-1)
- Impact Assessment Checklist (Annexure-2)
- Regulatory Variation Submission Template (Annexure-3)
References
- ICH Q10: Pharmaceutical Quality System
- FDA Guidance for Industry: Changes to an Approved NDA or ANDA
- EU GMP Annex 15: Qualification and Validation
- WHO Good Manufacturing Practices for Pharmaceutical Products
- Internal Change Control Policy and Procedures
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Change Request Form
Purpose: To formally document and initiate requests for post-approval changes ensuring proper evaluation and control.
| Change Request No. | CR-2026-015 |
| Date of Request | 01/03/2026 |
| Requested By (Dept) | Manufacturing |
| Description of Change | Upgrade of granulation equipment motor controller |
| Reason for Change | Improve process control and reliability |
| Expected Impact | No impact on product quality; enhanced process stability |
| Attachments | Technical Specification Document |
| Initiator Signature | |
| Date | 01/03/2026 |
Annexure-2: Impact Assessment Checklist
Purpose: To assess the regulatory, quality, operational, and safety impact of proposed post-approval changes ensuring informed decision-making.
| Assessment Parameter | Assessment Outcome | Comments |
|---|---|---|
| Regulatory Submission Required | Yes | Variation dossier to be prepared for submission |
| Impact on Product Quality | None | Validated motor controller upgrade expected to improve reliability |
| Validation Required | Yes | Re-qualification of equipment and process validation needed |
| Training Required | Yes | Operators and maintenance team to be trained on new controller |
| Safety Impact | No | No additional safety risks identified |
Annexure-3: Regulatory Variation Submission Template
Purpose: To document comprehensive information required for submission of post-approval changes to regulatory authorities in compliance with applicable guidelines.
| Submission ID | VAR-2026-045 |
| Date Prepared | 05/03/2026 |
| Product Name | Paracetamol Tablets 500mg |
| Change Description | Upgrade granulation equipment motor controller to improve process consistency |
| Supporting Documents | Change Request Form, Impact Assessment, Validation Protocol and Reports |
| Regulatory Impact Statement | No change in product formulation or specifications; compliance with GMP maintained |
| Prepared By | |
| Date | 05/03/2026 |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 11/04/2026 | 1.0 | Initial issue | New SOP creation |